<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Ra Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Ra Pharmaceuticals, Inc.

    Ra PharmaÂŽ is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas Treco, Ph.D.
    • FOUNDED
      2008
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Advaxis, Inc.

    Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of ca...

    Advaxis was founded on the vision that no one s...

    Filing Type:    PU
    Rian Enterprises, Inc.

    Rian Enterprises, Inc.

    Health Journal is a leader and influencer in health publishing in Virginia, USA an...

    Health Journal is a leader and influencer in he...

    Amount Raised:    $1,400.00
    Fundraising Status:    EC
    Filing Type:    CF
    Savara, Inc.

    Savara, Inc.

    Savara is an orphan lung disease company. Savara’s pipeline comprises Molgradex,...

    Savara is an orphan lung disease company. Savar...

    Filing Type:    PU
    TG Therapeutics, Inc.

    TG Therapeutics, Inc.

    TG Therapeutics is a biopharmaceutical company focused on the acquisition, develop...

    TG Therapeutics is a biopharmaceutical company ...

    Filing Type:    PU
    Soleno Therapeutics, Inc.

    Soleno Therapeutics, Inc.

    Soleno Therapeutics, Inc. (Soleno) is focused on the development and commercializa...

    Soleno Therapeutics, Inc. (Soleno) is focused o...

    Filing Type:    PU
    Venomyx, Inc

    Venomyx, Inc

    We're developing Vipax, the world's first portable, shelf-stable, broad-spectrum a...

    We're developing Vipax, the world's first porta...

    Amount Raised:    $290,122.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.